A Randomized, Double-Blind, Multi-Center, Repeat-Dose, Comparison of the Effects of Q8003 to the Morphine-Equivalent Doses of Oxycodone and of Morphine on the Opioid-Related Adverse Events of Moderate to Severe Nausea, Emesis, and Dizziness in Subjects With Acute Moderate-to-Severe Postoperative Pain Following Bunionectomy Surgery.

Trial Profile

A Randomized, Double-Blind, Multi-Center, Repeat-Dose, Comparison of the Effects of Q8003 to the Morphine-Equivalent Doses of Oxycodone and of Morphine on the Opioid-Related Adverse Events of Moderate to Severe Nausea, Emesis, and Dizziness in Subjects With Acute Moderate-to-Severe Postoperative Pain Following Bunionectomy Surgery.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Aug 2014

At a glance

  • Drugs Morphine/oxycodone (Primary) ; Morphine; Oxycodone
  • Indications Postoperative pain
  • Focus Adverse reactions; Registrational
  • Most Recent Events

    • 26 Jun 2013 A data amendment for Study 022 will be submitted to the revised NDA for MOXDUO, according to a QRxPharma media release.
    • 31 Aug 2012 Efficacy outcomes presented at the 14th World Congress on Pain.
    • 31 Aug 2012 Effects on oxygen desaturation presented at the 14th World Congress on Pain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top